Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease - Archive ouverte HAL Access content directly
Journal Articles Journal of Thrombosis and Haemostasis Year : 2014

Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease

S. Gaillard
  • Function : Author
S. Dupuis-Girod
  • Function : Author
F. Boutitie
S. Riviere
  • Function : Author
S. Moriniere
  • Function : Author
P. Y. Hatron
  • Function : Author
G. Manfredi
  • Function : Author
P. Kaminsky
  • Function : Author
A. L. Capitaine
  • Function : Author
H. Plauchu
  • Function : Author
No file

Dates and versions

hal-02071525 , version 1 (18-03-2019)

Identifiers

Cite

S. Gaillard, S. Dupuis-Girod, F. Boutitie, S. Riviere, S. Moriniere, et al.. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. Journal of Thrombosis and Haemostasis, 2014, 12, pp.1494-502. ⟨10.1111/jth.12654⟩. ⟨hal-02071525⟩
13 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More